ID   CO9_RAT                 Reviewed;         554 AA.
AC   Q62930; Q62957;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   29-MAY-2024, entry version 146.
DE   RecName: Full=Complement component C9;
DE   Flags: Precursor;
GN   Name=C9;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9212048; DOI=10.1203/00006450-199707000-00020;
RA   Lassiter H.A., Walz B.M., Wilson J.L., Jung E., Calisi C.R.,
RA   Goldsmith L.J., Wilson R.A., Morgan B.P., Feldhoff R.C.;
RT   "The administration of complement component C9 enhances the survival of
RT   neonatal rats with Escherichia coli sepsis.";
RL   Pediatr. Res. 42:128-136(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Hinchliffe S.J., Van den Berg C.W., Rushmere N.K., Morgan B.P.;
RT   "Cloning of rat C9: consequences for homologous restriction of
RT   complement.";
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Constituent of the membrane attack complex (MAC) that plays a
CC       key role in the innate and adaptive immune response by forming pores in
CC       the plasma membrane of target cells. C9 is the pore-forming subunit of
CC       the MAC. {ECO:0000269|PubMed:9212048}.
CC   -!- SUBUNIT: Component of the membrane attack complex (MAC). MAC assembly
CC       is initiated by proteolytic cleavage of C5 into C5a and C5b. C5b binds
CC       sequentially C6, C7, C8 and multiple copies of the pore-forming subunit
CC       C9. About 20 C9 chains oligomerize to give rise to a huge beta-barrel
CC       that forms a 100 Angstrom diameter pore in target membranes.
CC       {ECO:0000250|UniProtKB:P02748}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:9212048}. Target
CC       cell membrane {ECO:0000269|PubMed:9212048}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P02748}. Note=Secreted as soluble monomer.
CC       Oligomerizes at target membranes, forming a pre-pore. A conformation
CC       change then leads to the formation of a 100 Angstrom diameter pore.
CC       {ECO:0000250|UniProtKB:P02748}.
CC   -!- TISSUE SPECIFICITY: Detected in blood serum (at protein level).
CC       {ECO:0000269|PubMed:9212048}.
CC   -!- DEVELOPMENTAL STAGE: Detected at low levels in neonate blood serum.
CC       Levels increase throughout the first three weeks after birth.
CC       {ECO:0000269|PubMed:9212048}.
CC   -!- PTM: The structure of the human polymeric form indicates the existence
CC       of an additional disulfide bond compared to the mouse monomeric form.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the complement C6/C7/C8/C9 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA96528.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U49071; AAB38023.1; -; mRNA.
DR   EMBL; U52948; AAA96528.1; ALT_INIT; mRNA.
DR   RefSeq; NP_476487.1; NM_057146.1.
DR   AlphaFoldDB; Q62930; -.
DR   SMR; Q62930; -.
DR   BioGRID; 250734; 1.
DR   STRING; 10116.ENSRNOP00000018545; -.
DR   GlyCosmos; Q62930; 3 sites, No reported glycans.
DR   GlyGen; Q62930; 3 sites.
DR   iPTMnet; Q62930; -.
DR   PhosphoSitePlus; Q62930; -.
DR   SwissPalm; Q62930; -.
DR   PaxDb; 10116-ENSRNOP00000018545; -.
DR   GeneID; 117512; -.
DR   KEGG; rno:117512; -.
DR   AGR; RGD:620319; -.
DR   CTD; 735; -.
DR   RGD; 620319; C9.
DR   eggNOG; ENOG502QWHM; Eukaryota.
DR   InParanoid; Q62930; -.
DR   OrthoDB; 4572257at2759; -.
DR   Reactome; R-RNO-977606; Regulation of Complement cascade.
DR   PRO; PR:Q62930; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0005579; C:membrane attack complex; ISO:RGD.
DR   GO; GO:0044218; C:other organism cell membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0001906; P:cell killing; ISO:RGD.
DR   GO; GO:0006956; P:complement activation; IBA:GO_Central.
DR   GO; GO:0006957; P:complement activation, alternative pathway; IEA:UniProtKB-KW.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0031640; P:killing of cells of another organism; IEA:UniProtKB-KW.
DR   GO; GO:0051260; P:protein homooligomerization; ISO:RGD.
DR   CDD; cd00112; LDLa; 1.
DR   Gene3D; 2.10.25.10; Laminin; 1.
DR   Gene3D; 4.10.400.10; Low-density Lipoprotein Receptor; 1.
DR   Gene3D; 2.20.100.10; Thrombospondin type-1 (TSP1) repeat; 1.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR036055; LDL_receptor-like_sf.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR001862; MAC_perforin.
DR   InterPro; IPR020864; MACPF.
DR   InterPro; IPR020863; MACPF_CS.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   PANTHER; PTHR45742; COMPLEMENT COMPONENT C6; 1.
DR   PANTHER; PTHR45742:SF3; COMPLEMENT COMPONENT C9; 1.
DR   Pfam; PF00057; Ldl_recept_a; 1.
DR   Pfam; PF01823; MACPF; 1.
DR   PRINTS; PR00764; COMPLEMENTC9.
DR   SMART; SM00192; LDLa; 1.
DR   SMART; SM00457; MACPF; 1.
DR   SMART; SM00209; TSP1; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF57424; LDL receptor-like module; 1.
DR   SUPFAM; SSF82895; TSP-1 type 1 repeat; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01209; LDLRA_1; 1.
DR   PROSITE; PS50068; LDLRA_2; 1.
DR   PROSITE; PS00279; MACPF_1; 1.
DR   PROSITE; PS51412; MACPF_2; 1.
DR   PROSITE; PS50092; TSP1; 1.
PE   1: Evidence at protein level;
KW   Complement alternate pathway; Complement pathway; Cytolysis;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Immunity; Innate immunity;
KW   Membrane; Membrane attack complex; Reference proteome; Secreted; Signal;
KW   Target cell membrane; Target membrane; Transmembrane;
KW   Transmembrane beta strand.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..554
FT                   /note="Complement component C9"
FT                   /id="PRO_0000023607"
FT   TRANSMEM        316..332
FT                   /note="Beta stranded"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        337..356
FT                   /note="Beta stranded"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          40..93
FT                   /note="TSP type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          97..134
FT                   /note="LDL-receptor class A"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          136..518
FT                   /note="MACPF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00745"
FT   DOMAIN          519..549
FT                   /note="EGF-like"
FT   SITE            267..268
FT                   /note="Cleavage; by thrombin"
FT   CARBOHYD        261
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        409
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        423
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        41..76
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        52..86
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        55..92
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        99..110
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        105..123
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        117..132
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        140..179
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        519..535
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        522..537
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   DISULFID        539..548
FT                   /evidence="ECO:0000250|UniProtKB:P02748"
FT   CONFLICT        65
FT                   /note="I -> M (in Ref. 2; AAA96528)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        300
FT                   /note="K -> R (in Ref. 2; AAA96528)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   554 AA;  62281 MW;  9C885F76A1275649 CRC64;
     MASGVTITLA IAIFALEINA QAPEPTPREE PSADALLPID CRMSTWSQWS QCDPCLKQRF
     RSRSIEVFGQ FQGKSCADAL GDRQHCEPTQ ECEEVQENCG NDFQCETGRC IKRKLLCNGD
     NDCGDFSDES DCESDPRLPC RDRVVEESEL GRTAGYGINI LGMDPLGTPF DNEFYNGLCD
     RVRDGNTLTY YRKPWNVAFL AYETKADKNF RTENYEEQFE MFKTIVRDRT TSFNANLALK
     FTITEAPIKK VGVDEVSPEK NSSKPKDSSV DFQFSYFKKE NFQRLSSYLS QTKKMFLHVK
     GMIQLGRFVM RNRGVMLTTT FLDDVKALPV SYEKGEYFGF LETYGTHYSS SGSLGGLYEL
     IYVLDKASMK EKGVELSDVK RCLGFNLDVS LYTPLQTALE GPSLTANVNH SDCLKTGDGK
     VVNISRDHII DDVISFIRGG TRKQAVLLKE KLLRGAKTID VNDFINWASS LDDAPALISQ
     KLSPIYNLIP LTMKDAYAKK QNMEKAIEDY VNEFSARKCY PCQNGGTAIL LDGQCMCSCT
     IKFKGIACEI SKQR
//
